Aerie Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AERI Nasdaq 2834 http://www.aeriepharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aerie Pharmaceuticals Inc

Edited Transcript of AERI earnings conference call or presentation 7-Aug-19 9:00pm GMT - Oct 16th, 2019 11:15 pm
Aerie Pharmaceuticals Announces Appointment of Charlene E. Davis, Esq., as Vice President and Chief Compliance Officer - Oct 7th, 2019 10:30 am
Aerie Pharmaceuticals to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference - Sep 25th, 2019 11:30 am
Aerie Secures Positive CHMP Opinion for Eye Drug Rhokiinsa - Sep 23rd, 2019 5:20 pm
Aerie Pharmaceuticals Receives Positive CHMP Opinion for Rhokiinsa® in the European Union - Sep 20th, 2019 10:30 am
The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO - Sep 19th, 2019 11:39 am
Will Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) Need To Raise More Money? - Sep 19th, 2019 10:37 am
Aerie Pharmaceuticals Submits Prior Approval Supplement to the U.S. Food and Drug Administration to Allow Production of Rocklatan® (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% in its Athlone Ireland Facility - Sep 19th, 2019 10:30 am
Weekly CEO Buys Highlight - Sep 16th, 2019 3:46 pm
Aerie Pharmaceuticals Announces Full Exercise by Initial Purchasers of Option to Purchase Additional $41.25 Million Aggregate Principal Amount of Aerie’s 1.50% Convertible Senior Notes Due 2024 - Sep 11th, 2019 1:36 am
Aerie Pharmaceuticals Inc (AERI) CEO Vicente Jr Anido Bought $499,012 of Shares - Sep 9th, 2019 11:15 pm
These 2 Biotech Stocks Are Seeing Insider Buying Activity - Sep 9th, 2019 10:00 am
Aerie (AERI) Down 19.7% Since Last Earnings Report: Can It Rebound? - Sep 6th, 2019 1:31 pm
The Daily Biotech Pulse: Cheery Results For Sage's Depression Drug, UniQure Offering, Axsome Aces Study Of Headache Drug - Sep 5th, 2019 12:12 pm
Aerie Pharmaceuticals Upsizes and Prices Private Offering of $275 Million 1.50% Convertible Senior Notes Due 2024 - Sep 5th, 2019 12:20 am
Aerie Pharmaceuticals to Offer $250 Million Convertible Senior Notes Due 2024 - Sep 3rd, 2019 8:01 pm
Zuckerberg Sells Shares of Facebook - Aug 19th, 2019 5:56 pm